Spruce Biosciences Inc (SPRB)

04:34 AM

Spruce Biosciences (SPRB) director granted 1,700 stock options at 52.70 - Stock Titan

04:34 AM

04:30 AM

Director Camilla V. Simpson awarded 1,700 SPRB options at $52.70 strike - Stock Titan

04:30 AM

04:30 AM

Spruce Biosciences (SPRB) chair receives grant of 1,700 stock options - Stock Titan

04:30 AM

04:30 AM

Spruce Biosciences (NASDAQ: SPRB) grants director 1,700 options - Stock Titan

04:30 AM

04:30 AM

Spruce Biosciences (SPRB) grants director Keli Walbert 1,700 options - Stock Titan

04:30 AM

04:02 AM

Spruce Biosciences (SPRB) 2026 annual meeting and say-on-pay votes - Stock Titan

04:02 AM

12:00 PM

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy - Yahoo Finance

12:00 PM

May 22, 2026

Spruce Biosciences Inc (SPRB) Stock Price, Quote, News & History - Benzinga

May 22, 2026

May 21, 2026

SPRB: Directors elected, all proposals approved, and strategic plans funded for regulatory milestones - TradingView

May 21, 2026

May 21, 2026

SPRB: All proposals passed, with updates on financing, manufacturing, and regulatory milestones shared - TradingView

May 21, 2026

May 17, 2026

Wall Street Analysts Believe Spruce Biosciences (SPRB) Could Rally 181.21%: Here's is How to Trade - MSN

May 17, 2026

May 16, 2026

Is Spruce Biosciences (SPRB) Overvalued After Q1 2026 EPS Beat? - GuruFocus

May 16, 2026

May 15, 2026

Citadel entities, Kenneth Griffin hold ~5.1% of Spruce Biosciences (SPRB) - Stock Titan

May 15, 2026

May 15, 2026

Alyeska Group (SPRB) discloses 61,670-share position, 4.49% of float - Stock Titan

May 15, 2026

May 15, 2026

Leerink Partners Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Cuts Target Price to $120 - Moomoo

May 15, 2026

May 15, 2026

Squadron entities report 12,200 SPRB shares (0.9%) — SPRB - Stock Titan

May 15, 2026

May 15, 2026

Wellington Group discloses 48,796 shared dispositive shares in Spruce Biosciences (NASDAQ: SPRB) - Stock Titan

May 15, 2026

May 14, 2026

SPRB Maintains by Citizens -- Price Target Lowered to $150 - GuruFocus

May 14, 2026

May 14, 2026

Spruce Biosciences 1Q Research and Development Expenses $7.6M >SPRB - Moomoo

May 14, 2026

May 14, 2026

Spruce Biosciences, Inc. Stock 12‑Month Price Target Cut to $178.6, Implies 210% Upside - TradingView

May 14, 2026

May 14, 2026

Spruce Biosciences Is Maintained at Market Outperform by Citizens - Moomoo

May 14, 2026

May 14, 2026

Spruce Biosciences price target lowered to $150 from $170 at Citizens - TipRanks

May 14, 2026

May 14, 2026

Citizens lowers Spruce Biosciences stock price target on model update By Investing.com - Investing.com Nigeria

May 14, 2026

May 14, 2026

Citizens lowers Spruce Biosciences stock price target on model update - Investing.com

May 14, 2026

May 14, 2026

Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates - BioSpace

May 14, 2026

May 13, 2026

Spruce Biosciences (NASDAQ: SPRB) posts Q1 loss and bolsters cash - Stock Titan

May 13, 2026

May 13, 2026

Spruce Biosciences (SPRB) Progresses Towards Key Regulatory Mile - GuruFocus

May 13, 2026

May 13, 2026

Spruce Biosciences reports Q1 EPS ($8.94), consensus ($6.11) - TipRanks

May 13, 2026

May 13, 2026

Spruce Biosciences, Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Spruce Biosciences Reports Q1 2026 Financials, Advances TA-ERT Toward FDA Approval for MPS IIIB, and Strengthens Leadership Team - Minichart

May 13, 2026

May 13, 2026

Spruce Biosciences reports Q1 2026 loss of $12.3M, cash $54.1M and $107.3M preliminary April balance - TradingView

May 13, 2026

May 13, 2026

Spruce Biosciences (SPRB) boosts cash with $69M raise, funds TA‑ERT into 2027 - Stock Titan

May 13, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 07, 2026

Ikarian Capital, Neil Shahrestani file ownership of 121,356 SPRB shares (4.8%) - Stock Titan

May 07, 2026

May 06, 2026

SPRB Stock Price, Quote & Chart | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

May 06, 2026

May 05, 2026

Sagimet Biosciences Inc. (SGMT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

May 05, 2026

May 04, 2026

Spruce Biosciences appoints two commercial executives By Investing.com - Investing.com Australia

May 04, 2026

May 04, 2026

Spruce Biosciences Expands Leadership Team - Contract Pharma

May 04, 2026

May 04, 2026

Spruce Biosciences Adds Two Senior Commercial Executives as It Prepares Rare Disease Launch Strategy - citybiz

May 04, 2026

May 04, 2026

Spruce Biosciences appoints two commercial executives - Investing.com

May 04, 2026

May 04, 2026

Spruce Biosciences further strengthens its commercial leadership team with the appointments of Brian Walls as vice president, market access and Darren Johnson as vice president, commercial operations - marketscreener.com

May 04, 2026

May 04, 2026

Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations - ChartMill

May 04, 2026

Apr 29, 2026

SPRB Technical Analysis | Trend, Signals & Chart Patterns | SPRUCE BIOSCIENCES INC (NASDAQ:SPRB) - ChartMill

Apr 29, 2026

Apr 28, 2026

ExodusPoint entities file Schedule 13G on SPRB (SPRB) - Stock Titan

Apr 28, 2026

Apr 28, 2026

Spruce Biosciences (SPRB) Projected to Post Earnings on Tuesday - MarketBeat

Apr 28, 2026

Apr 27, 2026

SPRB Initiated Coverage by Craig-Hallum -- Rating Set to Buy - GuruFocus

Apr 27, 2026

Apr 27, 2026

Craig-Hallum initiates Spruce Biosciences stock with buy rating By Investing.com - Investing.com South Africa

Apr 27, 2026